DOI 10.1016/j.medj.2025.100802
Efficacy of JAK inhibitor combined with protein A immunoadsorption in MDA5+ dermatomyositis with RPILD: A real-world study.
Аннотация
BACKGROUND
Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5+ DM) with rapidly progressive interstitial lung disease (RPILD) is a fatal disease. Although Janus kinase inhibitors (JAKi) hold their promise in treating MDA5+ DM, regimen for RPILD is still urgently needed to improve the adverse prognosis.
METHODS
Based on a large inception cohort of MDA5+ DM, patients with RPILD (oxygen index [OI] < 300 within the first 3 months of disease duration) were included. Patients who received protein A immunoadsorption plus a JAKi were compared to those treated with JAKi alone. Propensity score matching (PSM) was performed to adjust confounding factors. Survival analysis was conducted to evaluate the efficacy of immunoadsorption add-on.
FINDINGS: From October 2017 to April 2024, a total of 152 newly diagnosed MDA5+ DM patients with RPILD were eligible for analyses. Thirty-four patients who underwent immunoadsorption with JAKi (ProJAK group) and 68 patients who received JAKi with or without other immunosuppressants combination (JAK group) as controls were compared after 1:2 PSM. The 6-month transplantation-free survival was significantly improved from 16.2% in the JAK group to 41.2% in the ProJAK group (p = 0.004). Subgroup analysis suggested that ProJAK therapy tended to have a more significant survival gain in patients with OI < 200. The most common adverse effect of ProJAK was transient immunoglobin decrease, but the infectious rate was similar between the 2 groups.
CONCLUSIONS
Immunoadsorption in combination with JAKi might be a promising treatment approach for MDA5+ DM patients with RPILD.
FUNDING: This work was supported by NFSC and SHDC.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.